Evidence map›Paper›PMID 33394115›Full record

ArticlePediatric cardiology2021

Impact of Reverse Left Ventricular Remodeling on Outcomes of Patients with Anomalous Left Coronary Artery from the Pulmonary Artery after Surgical Correction.

Hongju Zhang, Tao Sun, Guowen Liu, Chayakrit Krittanawong, Edward A El-Am, Roukoz A Abou Karam, Yan Sun, Jiao Yang, Jingya Li, Xin Zhang and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Hongju Zhang *Department of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Tao Sun *Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guowen LiuDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Chayakrit KrittanawongSection of Cardiology, Baylor College of Medicine, Houston, TX, USA.
Edward A El-AmDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Roukoz A Abou KaramThe Cardiovascular Division Department of Medicine, Beth Israel Deaconess Medical Center Harvard Medical School, Boston Massachusetts, USA.
Yan SunDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Jiao YangDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Jingya LiDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Xin ZhangDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Li XueDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Jun WangDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Yuqiong AnDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Guiqin MaDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Ning MaDepartment of Echocardiography, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. maning_echo@163.com.
Beijing Children’s Hospital · CNCapital Medical University · CNBaylor College of Medicine · USBeijing Anzhen Hospital · CNHarvard University · USIndiana University – Purdue University Indianapolis · US

Funding

Natural Science Foundation of Beijing Municipality 7192062Natural Science Foundation of Beijing Municipality 7202046Shanxi Provincial Key Research and Development Project 201903D321177
6 · The paper itself

Abstract

The impact of reverse left ventricular remodeling (r-LVR) on clinical outcomes after surgical correction of anomalous left coronary artery from the pulmonary artery (ALCAPA) remains unclear. This study aims to examine the prognostic significance of r-LVR in patients with ALCAPA after surgery. We prospectively identified 61 patients undergoing surgical correction for ALCAPA; 54 patients had adequate echocardiographic image quality with quantitative biplane analysis performed both at baseline and at 30-day postoperative follow-up. Postoperative r-LVR was defined as a reduction of ≥ 10% in left ventricular end-diastolic volume index during follow-up. Cox proportional-hazards regression was used to investigate the independent association of r-LVR and all-cause mortality. Among 54 patients (age: 21.2 ± 7 months; 37% females), r-LVR occurred in 35 patients (64.8%) after surgery. Compared to patients with r-LVR, patients without r-LVR had significantly higher level of N-terminal pro B-type natriuretic peptide (NT-proBNP) [2176 (711, 4219) vs 998 (623, 2145) P < 0.001] and lower survival rate (47.3% vs 82.9%, HR = 5.72 [1.96 to 17.20], P < 0.001) at 1-year follow-up. NT-proBNP (OR = 2.27 [1.67 to 18.3], P = 0.02) was an independent predictor of r-LVR in multivariate analysis. Moreover, r-LVR was significantly associated with a lower rate of all-cause mortality (HR = 0.27 [0.08 to 0.98], P = 0.03) in multivariate analysis, even after adjustment for clinical and echocardiographic variables. R-LVR occurred in more than half of patients with ALCAPA undergoing surgical correction and it was associated with better clinical outcomes. NT-proBNP is an independent predictor of r-LVR.

Indexed as

Ventricular RemodelingAnomalous Left Coronary ArteryCase-Control StudiesChild, PreschoolEchocardiographyFemaleHumansInfantMaleNatriuretic Peptide, BrainPeptide FragmentsPostoperative ComplicationsProspective StudiesPulmonary ArteryNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)ALCAPAClinical outcomesr-LVRSurgical correction

Identifiers

PMID33394115
OpenAlexW3119774857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.